Banks - Regional
Compare Stocks
5 / 10Stock Comparison
BRBS vs NBTB vs CARE vs NKSH vs MNSB
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
BRBS vs NBTB vs CARE vs NKSH vs MNSB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $320M | $2.35B | $580M | $240M | $176M |
| Revenue (TTM) | $151M | $867M | $255M | $85M | $136M |
| Net Income (TTM) | $11M | $169M | $31M | $16M | $16M |
| Gross Margin | 63.5% | 72.1% | 61.7% | 65.1% | 54.4% |
| Operating Margin | 9.1% | 25.3% | 15.7% | 22.5% | 14.0% |
| Forward P/E | 31.8x | 10.8x | 4.8x | 11.7x | 10.4x |
| Total Debt | $179M | $327M | $179M | $2M | $70M |
| Cash & Equiv. | $116M | $185M | $105M | $8M | $25M |
BRBS vs NBTB vs CARE vs NKSH vs MNSB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Blue Ridge Bankshar… (BRBS) | 100 | 36.0 | -64.0% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
| National Bankshares… (NKSH) | 100 | 122.4 | +22.4% |
| MainStreet Bancshar… (MNSB) | 100 | 177.2 | +77.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRBS vs NBTB vs CARE vs NKSH vs MNSB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRBS has the current edge in this matchup, primarily because of its strength in income & stability and defensive.
- Dividend streak 0 yrs, beta 0.54, yield 6.1%
- Beta 0.54, yield 6.1%
- NIM 3.2% vs NKSH's 2.5%
- Beta 0.54 vs NBTB's 0.89
NBTB is the #2 pick in this set and the best alternative if growth and value is your priority.
- 10.4% NII/revenue growth vs BRBS's -13.4%
- Lower P/E (10.8x vs 11.7x), PEG 1.53 vs 145.48
CARE is the clearest fit if your priority is long-term compounding.
- 112.9% 10Y total return vs MNSB's 126.9%
- +69.0% vs NBTB's +9.0%
NKSH is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 7.9%, EPS growth 100.8%
- Lower volatility, beta 0.76, Low D/E 1.1%, current ratio 1203.84x
MNSB ranks third and is worth considering specifically for quality and efficiency.
- Efficiency ratio 0.4% vs BRBS's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs BRBS's 0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% NII/revenue growth vs BRBS's -13.4% | |
| Value | Lower P/E (10.8x vs 11.7x), PEG 1.53 vs 145.48 | |
| Quality / Margins | Efficiency ratio 0.4% vs BRBS's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.54 vs NBTB's 0.89 | |
| Dividends | 6.1% yield, vs NBTB's 3.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +69.0% vs NBTB's +9.0% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs BRBS's 0.5% |
BRBS vs NBTB vs CARE vs NKSH vs MNSB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRBS vs NBTB vs CARE vs NKSH vs MNSB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 1 of 6 categories
NKSH leads 1 • CARE leads 1 • BRBS leads 0 • MNSB leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 10.2x NKSH's $85M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to BRBS's 7.1%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $151M | $867M | $255M | $85M | $136M |
| EBITDAEarnings before interest/tax | $15M | $241M | $46M | $20M | $23M |
| Net IncomeAfter-tax profit | $11M | $169M | $31M | $16M | $16M |
| Free Cash FlowCash after capex | $9M | $225M | $30M | $17M | $13M |
| Gross MarginGross profit ÷ Revenue | +63.5% | +72.1% | +61.7% | +65.1% | +54.4% |
| Operating MarginEBIT ÷ Revenue | +9.1% | +25.3% | +15.7% | +22.5% | +14.0% |
| Net MarginNet income ÷ Revenue | +7.1% | +19.5% | +12.3% | +18.6% | +11.5% |
| FCF MarginFCF ÷ Revenue | +2.5% | +25.2% | +12.5% | +17.8% | +7.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +2.6% | +39.5% | +8.3% | +91.7% | +120.9% |
Valuation Metrics
Evenly matched — NBTB and MNSB each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 13.4x trailing earnings, MNSB trades at a 58% valuation discount to BRBS's 31.8x P/E. Adjusting for growth (PEG ratio), NBTB offers better value at 1.92x vs NKSH's 145.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $320M | $2.4B | $580M | $240M | $176M |
| Enterprise ValueMkt cap + debt − cash | $383M | $2.5B | $654M | $234M | $221M |
| Trailing P/EPrice ÷ TTM EPS | 31.82x | 13.53x | 18.71x | 15.14x | 13.36x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.80x | 4.77x | 11.71x | 10.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.92x | — | 145.48x | — |
| EV / EBITDAEnterprise value multiple | 25.54x | 10.35x | 16.34x | 12.20x | 11.58x |
| Price / SalesMarket cap ÷ Revenue | 2.13x | 2.71x | 2.28x | 2.81x | 1.30x |
| Price / BookPrice ÷ Book value/share | 1.15x | 1.21x | 1.40x | 1.30x | 0.82x |
| Price / FCFMarket cap ÷ FCF | 85.53x | 10.75x | 18.25x | 15.85x | 16.57x |
Profitability & Efficiency
NKSH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NBTB delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $3 for BRBS. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRBS's 0.55x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.1% | +9.5% | +7.6% | +9.0% | +7.3% |
| ROA (TTM)Return on assets | +0.4% | +1.1% | +0.7% | +0.9% | +0.7% |
| ROICReturn on invested capital | +2.0% | +7.9% | +5.7% | +8.4% | +5.0% |
| ROCEReturn on capital employed | +0.5% | +2.4% | +1.5% | +1.9% | +0.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 8 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.55x | 0.17x | 0.43x | 0.01x | 0.32x |
| Net DebtTotal debt minus cash | $63M | $142M | $73M | -$6M | $45M |
| Cash & Equiv.Liquid assets | $116M | $185M | $105M | $8M | $25M |
| Total DebtShort + long-term debt | $179M | $327M | $179M | $2M | $70M |
| Interest CoverageEBIT ÷ Interest expense | 0.23x | 1.05x | 0.39x | 0.64x | 0.31x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $3,234 for BRBS. Over the past 12 months, CARE leads with a +69.0% total return vs NBTB's +9.0%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.9% vs BRBS's -17.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.4% | +9.3% | +34.8% | +14.2% | +19.4% |
| 1-Year ReturnPast 12 months | +24.6% | +9.0% | +69.0% | +49.7% | +26.4% |
| 3-Year ReturnCumulative with dividends | -43.9% | +54.1% | +94.7% | +55.1% | +21.5% |
| 5-Year ReturnCumulative with dividends | -67.7% | +29.9% | +87.2% | +31.9% | +20.6% |
| 10-Year ReturnCumulative with dividends | -12.5% | +102.2% | +112.9% | +51.3% | +126.9% |
| CAGR (3Y)Annualised 3-year return | -17.5% | +15.5% | +24.9% | +15.7% | +6.7% |
Risk & Volatility
Evenly matched — BRBS and CARE each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRBS is the less volatile stock with a 0.54 beta — it tends to amplify market swings less than NBTB's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 98.5% from its 52-week high vs BRBS's 73.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.54x | 0.89x | 0.56x | 0.76x | 0.66x |
| 52-Week HighHighest price in past year | $4.79 | $46.92 | $26.58 | $40.00 | $25.17 |
| 52-Week LowLowest price in past year | $3.25 | $39.20 | $15.37 | $24.74 | $17.86 |
| % of 52W HighCurrent price vs 52-week peak | +73.1% | +96.1% | +98.5% | +94.3% | +93.4% |
| RSI (14)Momentum oscillator 0–100 | 35.1 | 57.3 | 75.4 | 51.1 | 50.4 |
| Avg Volume (50D)Average daily shares traded | 380K | 236K | 276K | 50K | 58K |
Analyst Outlook
Evenly matched — BRBS and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NBTB as "Hold", CARE as "Buy", NKSH as "Buy", MNSB as "Hold". Consensus price targets imply 3.1% upside for CARE (target: $27) vs 2.1% for NBTB (target: $46). For income investors, BRBS offers the higher dividend yield at 6.08% vs NBTB's 3.17%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $46.00 | $27.00 | — | — |
| # AnalystsCovering analysts | — | 10 | 4 | 4 | 1 |
| Dividend YieldAnnual dividend ÷ price | +6.1% | +3.2% | — | +4.0% | — |
| Dividend StreakConsecutive years of raises | 0 | 12 | 0 | 1 | 2 |
| Dividend / ShareAnnual DPS | $0.21 | $1.43 | — | $1.51 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | +0.4% | +3.4% | 0.0% | 0.0% |
NBTB leads in 1 of 6 categories (Income & Cash Flow). NKSH leads in 1 (Profitability & Efficiency). 3 tied.
BRBS vs NBTB vs CARE vs NKSH vs MNSB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRBS or NBTB or CARE or NKSH or MNSB a better buy right now?
For growth investors, NBT Bancorp Inc.
(NBTB) is the stronger pick with 10. 4% revenue growth year-over-year, versus -13. 4% for Blue Ridge Bankshares, Inc. (BRBS). MainStreet Bancshares, Inc. (MNSB) offers the better valuation at 13. 4x trailing P/E (10. 4x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRBS or NBTB or CARE or NKSH or MNSB?
On trailing P/E, MainStreet Bancshares, Inc.
(MNSB) is the cheapest at 13. 4x versus Blue Ridge Bankshares, Inc. at 31. 8x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NBT Bancorp Inc. wins at 1. 53x versus National Bankshares, Inc. 's 145. 48x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BRBS or NBTB or CARE or NKSH or MNSB?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to -67. 7% for Blue Ridge Bankshares, Inc. (BRBS). Over 10 years, the gap is even starker: MNSB returned +126. 9% versus BRBS's -12. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRBS or NBTB or CARE or NKSH or MNSB?
By beta (market sensitivity over 5 years), Blue Ridge Bankshares, Inc.
(BRBS) is the lower-risk stock at 0. 54β versus NBT Bancorp Inc. 's 0. 89β — meaning NBTB is approximately 64% more volatile than BRBS relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 55% for Blue Ridge Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BRBS or NBTB or CARE or NKSH or MNSB?
By revenue growth (latest reported year), NBT Bancorp Inc.
(NBTB) is pulling ahead at 10. 4% versus -13. 4% for Blue Ridge Bankshares, Inc. (BRBS). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 12. 5% for NBT Bancorp Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRBS or NBTB or CARE or NKSH or MNSB?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 7. 1% for Blue Ridge Bankshares, Inc. — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 9. 1% for BRBS. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRBS or NBTB or CARE or NKSH or MNSB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NBT Bancorp Inc. (NBTB) is the more undervalued stock at a PEG of 1. 53x versus National Bankshares, Inc. 's 145. 48x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 11. 7x for National Bankshares, Inc. — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 1% to $27. 00.
08Which pays a better dividend — BRBS or NBTB or CARE or NKSH or MNSB?
In this comparison, BRBS (6.
1% yield), NKSH (4. 0% yield), NBTB (3. 2% yield) pay a dividend. CARE, MNSB do not pay a meaningful dividend and should not be held primarily for income.
09Is BRBS or NBTB or CARE or NKSH or MNSB better for a retirement portfolio?
For long-horizon retirement investors, Blue Ridge Bankshares, Inc.
(BRBS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 54), 6. 1% yield). Both have compounded well over 10 years (BRBS: -12. 5%, MNSB: +126. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRBS and NBTB and CARE and NKSH and MNSB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BRBS is a small-cap income-oriented stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; NKSH is a small-cap deep-value stock; MNSB is a small-cap deep-value stock. BRBS, NBTB, NKSH pay a dividend while CARE, MNSB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.